..............page:809-813
..............page:813-813
A multicenter study on the revalidation of validated conversion factor for the conversion of BCR-ABL(P210)transcript levels to the international scale in chronic myeloid leukemia
Qin Yazhen;,Ma Daoxin;,Wang Yungui;,Wang Lili;,Wang Yue;,Liu Shengwei;,Lu Xiaojun;,Li Xiaoqing;,Cen Jiannong;,Xiao Min;,Lin Zhenxing;,Geng Suxia;,Liang Chao;,Cheng Hui;,Han Cong;,Han Wei;,Huang Xiaojun;
..............page:814-817
..............page:817-817
Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome
Wang Wei;,Chen Zhimei;,Yu Mengxia;,Wang Huanping;,Lou Jiyu;,Xu Huan;,Hu Chao;,Mu Qitian;,Tong Hongyan;,Wei Juying;,Zhou Xinping;,Jin Jie;
..............page:818-823
..............page:823-823
..............page:824-829
Therapeutic effect of CY-fTBI and BMM conditioning regimen in the process of allo-HSCT treatingⅢ,Ⅳnon-Hodgkin lymphoma:15 years analysis of single-center
Sun Ting;,Hu Liangding;,Jiang Min;,Ning Hongmei;,Zhang Bin;,Ren Jing;,Li Yuhang;,Li Botao;,Chen Jianlin;,Yang Fan;,Xu Chen;,Wang Jun;,Lou Xiao;,Hu Jiangwei;,Chen Hu;
..............page:830-834
..............page:834-834
..............page:834-834
..............page:835-839
..............page:840-843
..............page:844-848
..............page:849-852
..............page:853-857
..............page:857-857
..............page:858-861
..............page:862-865
..............page:866-867
..............page:868-869
..............page:870-872
..............page:872-875
..............page:876-877
..............page:878-882
..............page:882-882
..............page:883-887
..............page:887-887
..............page:888-893
..............page:894-896